RXI Pharma (RXII) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. USO
5. TSLA
6. GNK
7. FNGR
8. PLUR
9. MU
10. ARGX

Go back to RXI Pharma (RXII) Tops Q2 EPS by 2c

RXi Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Corporate Developments

August 11, 2016 7:02 AM EDT

MARLBOROUGH, Mass., Aug. 11, 2016 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today reported its financial results for the second quarter ended June 30, 2016, and provided a business update.

Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO

"First of all, I am proud to report that careful execution of RXi's clinical programs by our team has resulted in... More